Conference Coverage

Findings set stage for immunomodulatory approaches in breast cancer

Publish date: December 18, 2013

 

AT SABCS 2013

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Surgery adds little after successful chemo in metastatic breast cancer
MDedge Internal Medicine
Exercise dampens aromatase inhibitor–related joint pain
MDedge Internal Medicine
SABCS Roundtable with Dr. Howard Burris and Dr. William Gradishar
MDedge Internal Medicine
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge Internal Medicine
New mega-review underscores mammography’s benefits
MDedge Internal Medicine
Veliparib-carboplatin combo is first 'graduate' of I-SPY2 trial
MDedge Internal Medicine
Meeting attendees identify top studies presented at SABCS
MDedge Internal Medicine
'Vogl, New York' offers San Antonio perspectives
MDedge Internal Medicine
Add-on agents boost neoadjuvant chemo response in triple-negative disease
MDedge Internal Medicine
Breast MRI screening finds undetected cancers in 11 per 1,000 average-risk women
MDedge Internal Medicine